Cencora, Inc.

NYSE:COR

Medical - Distribution

Healthcare
$348.31 -2.04%

-$5.65 today

Market cap
$66.47B
Beta
0.59
P/E (TTM)
20.7
EPS (TTM)
$13.10
Dividend yield
0.87%
52W Low $244.82High $377.54

Volume 1.20M

Average 1.78M

COR Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Cencora, Inc.NYSE: COR

Gross Margin · Q3 FY2026 · quarter ended Jun 2026

Gross margin widens to 4.3%

Gross margin was 4.3% in Q3 FY2026, up 1.0 pp from a year earlier. On a trailing-twelve-month basis it was 3.7%, up 0.6 pp year over year. Over 3 fiscal years it narrowed by 0.0 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
4.3%+0.0 pp QoQ
Last fiscal yearSep 2025
3.2%+0.2 pp YoY
LTMJun 2026
3.7%+0.6 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1.0 pp——
1 year+0.2 pp——
3 years-0.0 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
3.2%
Year-over-year change
+0.2pp

Gross Margin vs competitors

How COR compares with its peers on the latest reported figures

  • COR's LTM Jun 2026 gross margin of 3.7% is the 4th highest of the 5 companies compared; the peer median is 17.1%.
  • Its year-over-year change of +0.6 pp is the 3rd highest of 5, against a peer median of +0.6 pp.
  • Over three fiscal years its change of -0.0 pp compares with a peer median of +0.4 pp.
COR Competitors Peer median
Gross Margin for COR and competitors
Company Period LTM level YoY 3-year change
ACHAccendra Health, Inc.LTM Mar 202641.3% +15.1 pp+25.2 pp
HSICHenry Schein, Inc.LTM Jun 202630.3% +1.0 pp+0.3 pp
CAHCardinal Health, Inc.LTM Sep 20263.9% +0.2 pp+0.5 pp
CORCencora, Inc.LTM Jun 20263.7% +0.6 pp-0.0 pp
MCKMcKesson CorporationLTM Jun 20263.6% +0.3 pp-0.7 pp
Peer median (excluding COR) 17.1%+0.6 pp+0.4 pp

Competitors are the stored peer set for COR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue213.99B238.59B262.17B293.96B321.33B
Cost of Revenue207.72B230.99B254.42B285.26B311.19B
Gross Profit6.27B7.6B7.76B8.7B10.14B
Gross Margin2.9%3.2%3.0%3.0%3.2%
Research & Development00000
Selling, General & Admin3.59B4.85B5.31B5.66B6.49B
Operating Expenses3.59B4.85B5.31B5.66B6.49B
Depreciation & Amortization514.79M709.84M980.85M1.12B1.07B
EBITDA2.92B3.12B3.42B3.37B3.75B
EBITDA Margin1.4%1.3%1.3%1.1%1.2%
Operating Income2.68B2.75B2.45B3.04B3.65B
Operating Margin1.3%1.2%0.9%1.0%1.1%
Interest Income8.47M21.31M46.72M91.69M128.21M
Interest Expense182.54M231.98M275.65M248.68M419.75M
Other Income / Expenses(453.15M)(568.62M)(285.68M)(1.04B)(1.39B)
Income Before Tax2.22B2.18B2.16B2B2.26B
Pre-Tax Margin1.0%0.9%0.8%0.7%0.7%
Income Tax Expense677.25M516.52M428.26M484.7M690.52M
Net Income1.54B1.7B1.75B1.51B1.55B
Net Margin0.7%0.7%0.7%0.5%0.5%
EPS (Basic)7.488.158.627.608.02
EPS (Diluted)7.398.048.537.537.96
Weighted Avg Shares205.92M208.47M204.59M198.5M193.82M
Weighted Avg Shares (Diluted)208.47M211.21M204.59M200.28M195.21M

Cencora, Inc.

NYSE:COR

Intrinsic Alpha fair value

Locked

Current Price

$348.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.